Comments

X4 Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does X4 Pharmaceuticals (XFOR) operate in?

X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

XFORNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.3401

0.027.42%

At close: -

$0.3399

-0.00020-0.06%

After Hours: Mar 14, 7:19 PM EDT

Q4 2024 Earnings in 9 days from now on Tue Mar 25th, before the market open

X4 Pharmaceuticals (XFOR) Forecast

News Earnings X4 Pharmaceuticals (XFOR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

X4 Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:XFOR | Benzinga

Explore X4 Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for XFOR.

Open	$0.33
Close	$0.34
Volume / Avg.	1.48M / 3.81M
Day Range	$0.32 - $0.35
52 Wk Range	0.26 - 1.60
Market Cap	$57.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	5.61%
Days to Cover	7.2

Recent News

Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Avi Kapoor

5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More

Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.

Shanthi Rexaline

FDA Approves X4 Pharmaceuticals' Mavorixafor As First Therapy For Rare Immunodeficiency Disorder

FDA approves Xolremdi capsules for WHIM syndrome, boosting neutrophil & lymphocyte counts. First therapy for this rare immunodeficiency disorder. Potential sales forecasted at $54.6M in 2024, rising to $450.9M by 2027.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.33
Close	$0.34
Volume / Avg.	1.48M / 3.81M
Day Range	$0.32 - $0.35
52 Wk Range	0.26 - 1.60
Market Cap	$57.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	5.61%
Days to Cover	7.2

About X4 Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research an...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy X4 Pharmaceuticals (XFOR) stock?

You can purchase shares of X4 Pharmaceuticals (NASDAQ:XFOR) through any online brokerage.

View our list of the best stock brokerages

Who are X4 Pharmaceuticals (XFOR) competitors?

Other companies in X4 Pharmaceuticals’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Fortress Biotech (NASDAQ:FBIO), CytomX Therapeutics (NASDAQ:CTMX), Gain Therapeutics (NASDAQ:GANX) and Connect Biopharma Hldgs (NASDAQ:CNTB).

What is the forecast, or price target, for X4 Pharmaceuticals (XFOR) stock?

X4 Pharmaceuticals has a consensus price target of $3.94.

What is the current price for X4 Pharmaceuticals (XFOR)?

The stock price for X4 Pharmaceuticals (NASDAQ: XFOR) is $0.3399 last updated March 14, 2025 at 7:19 PM EDT.

Does X4 Pharmaceuticals (XFOR) pay a dividend?

There are no upcoming dividends for X4 Pharmaceuticals.

When is X4 Pharmaceuticals (NASDAQ:XFOR) reporting earnings?

X4 Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is X4 Pharmaceuticals (XFOR) going to split?

There is no upcoming split for X4 Pharmaceuticals.

What sector and industry does X4 Pharmaceuticals (XFOR) operate in?

X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.